CD19 CAR T-cell therapy with CD34 selection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19 CAR T-cell therapy with CD34 selection, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL [Phase 1, Phase 2]